Company
1200 Pharma
- Business model
- B2B
- Headquarters
- Pasadena, CA, United States
Claim, correct or request removal
Record updated 28 September 2026
About
Headquartered in Pasadena, CA, 1200 Pharma is developing novel oncology therapeutics utilizing breakthrough medicinal chemistry technology from Caltech and proprietary biomarker-driven assays from UCLA to dramatically accelerate pre-clinical drug discovery and clinical approval timelines.
Funding snapshot
- Total raised
- $14.1MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $2.3M2024-04-15
Funding rounds
- Round, 2024
- $2.3M2024-04-15, SEC form D sold, 30 investors
- Round, 2019
- $5.5M2019-11-26, SEC form D sold, 5 investors
- Round, 2017
- $6.2M2017-11-15, SEC form D sold, 2 investors
Loading relationship preview